Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes.

Residual β-cell function is associated with improved nocturnal and postprandial glycaemic control. These data may be of clinical importance for identifying specific periods and individuals where further glycaemic management strategies would be beneficial.